Affiliation:
1. Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland, Switzerland
2. SolidarMed, Partnerships for Health, Maseru, Lesotho
3. Mokhotlong District Health Management Team, Mokhotlong, Ministry of Health Lesotho
4. University Hospital of Basel
Abstract
Abstract
In Lesotho, the hypertension and diabetes care cascades are unknown. We measured awareness, treatment, and control of hypertension and diabetes and identified factors associated with each step of the cascade, based on data from a population-based, cross-sectional survey among adults ≥ 18 years in 120 randomly sampled clusters in the districts of Butha-Buthe and Mokhotlong from 1st November 2021 to 31st August 2022. We used multivariable logistic regression to assess associations. Among participants with hypertension, 69.7% (95%CI, 67.2–72.2%, 909/1305) were aware of their condition, 67.3% (95%CI 64.8–69.9%, 878/1305) took treatment, and 49.0% (95%CI 46.3–51.7%, 640/1305) were controlled. Among participants with diabetes, 48.4% (95%CI 42.0–55.0%, 111/229) were aware of their condition, 55.8% (95%CI 49.5–62.3%, 128/229) took treatment, and 41.5% (95%CI 35.1–47.9%, 95/229) were controlled. For hypertension, women had higher odds of being on treatment (adjusted odds ratio (aOR) 2.54, 95% CI 1.78–3.61) and controlled (aOR 2.44, 95%CI 1.76–3.37) than men. Participants from urban areas had lower odds of being on treatment (aOR 0.63, 95% CI 0.44–0.90) or being controlled (aOR 0.63, 95% CI 0.46–0.85). Considerable gaps along the hypertension and diabetes care cascades in Lesotho indicate that access and quality of care for these conditions are insufficient to ensure adequate health outcomes.
Publisher
Research Square Platform LLC
Reference50 articles.
1. The global epidemiology of hypertension;Mills KT;Nat Rev Nephrol,2020
2. Modifiable risk factors, cardiovascular disease, and mortality in 155†722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study;Yusuf S;Lancet,2020
3. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants;Zhou B;The Lancet,2021
4. Saeedi, P. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice 157, (2019).
5. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories;Foreman KJ;Lancet,2018